Revised SPC: Sporanox (itraconazole) oral suspension

SPC now notes that in cystic fibrosis patients, variability in plasma levels of itraconazole leading to subtherapeutic concentrations has been observed. If no response to oral solution, consideration should be given to switching to itraconazole IV or to alternative therapy.

Source:

electronic Medicines compendium